The ONE Study nTreg Trial (ONEnTreg13)

NCT02371434 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Immunosuppressive Treatment of Living-donor Renal Transplantation

Interventions

BIOLOGICAL: autologous CD4+CD25+FoxP3+ natural regulat. T cells (nTregs)

Sponsor

Prof. Dr. Petra Reinke